China's FDA, chronically understaffed for its large workload, faces another problem as well: once its staff members gain experience, they leave for enticing industry jobs that pay $92,000, five times their government salaries, according to a Reuters article. Experienced government regulators become valuable pharma staff members, people who know the CFDA's procedures and have strong contacts in the agency. The revolving door is one more obstacle in the CFDA's ongoing battle to provide effective drugs and prevent fraud in China healthcare system.
